Journal of Cancer Research and Therapeutics Close
 

Figure 1: (a) Survival curve of progression-free survival in patients treated with sintilimab (n = 37) and (b) Survival curve of overall survival in patients treated with sintilimab (n = 37)

Figure 1: (a) Survival curve of progression-free survival in patients treated with sintilimab (n = 37) and (b) Survival curve of overall survival in patients treated with sintilimab (<i>n</i> = 37)